To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05973864
Title Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery (CAPPA)
Acronym CAPPA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Hospitalier de la Côte Basque RECRUITING Bayonne 64109 France Details
CHD Vendee RECRUITING La Roche Sur Yon France Details
Institut Curie RECRUITING Paris 75005 France Details
Clinique de La Croix du sud RECRUITING Quint-fonsegrives 31130 France Details
Institut Godinot RECRUITING Reims 51100 France Details
Institut Curie RECRUITING Saint-Cloud 92210 France Details
Institut Claudius Regaud, IUCT Oncopole RECRUITING Toulouse France Details
Institut de Cancérologie de Lorraine RECRUITING Vandoeuvre Les Nancy Cedex 54519 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field